Subscribe To
BDSI / Has BioDelivery Sciences International (BDSI) Outpaced Other Medical Stocks This Year?
BDSI News
By Zacks Investment Research
March 18, 2022
Has BioDelivery Sciences International (BDSI) Outpaced Other Medical Stocks This Year?
Here is how BioDelivery Sciences International (BDSI) and Vertex Pharmaceuticals (VRTX) have performed compared to their sector so far this year. more_horizontal
By Zacks Investment Research
March 2, 2022
Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline
BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared wi more_horizontal
By Zacks Investment Research
March 2, 2022
Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline
BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared wi more_horizontal
By Zacks Investment Research
March 2, 2022
Earnings Preview: BioDelivery Sciences International (BDSI) Q4 Earnings Expected to Decline
BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared wi more_horizontal
By Zacks Investment Research
February 15, 2022
BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium
Collegium (COLL) is set to acquire BioDelivery (BDSI) for approximately $604 million in cash. The transaction is likely to be completed by the end of more_horizontal
By Zacks Investment Research
February 15, 2022
BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium
Collegium (COLL) is set to acquire BioDelivery (BDSI) for approximately $604 million in cash. The transaction is likely to be completed by the end of more_horizontal
By Zacks Investment Research
February 15, 2022
BioDelivery (BDSI) Stock Surges on Buyout Offer From Collegium
Collegium (COLL) is set to acquire BioDelivery (BDSI) for approximately $604 million in cash. The transaction is likely to be completed by the end of more_horizontal
By InvestorPlace
February 14, 2022
BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing Today
Today, a big takeover announcement has sent shares of BioDelivery and BDSI stock soaring more than 50% on investor enthusiasm for this deal. The post more_horizontal